Regentatlantic Capital LLC Azur Rx Bio Pharma, Inc. Transaction History
Regentatlantic Capital LLC
- $3.34 Billion
- Q3 2022
About AzurRx BioPharma, Inc.
- Ticker AZRX
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 78,575,104
- Market Cap $271M